NEWS
Oaktree Capital Management now keen on GenesisCare deal
SYDNEY: Opportunistic Oaktree Capital Management has set its sights on restructuring candidate GenesisCare, lobbing a… read more
Telix boss rules out capital raising as shares soar
MELBOURNE: Telix Pharmaceuticals boss Christian Behrenbruch has ruled out a capital raising to accelerate the… read more
Mayne Pharma set to defer capital return to investors
MELBOURNE: Mayne Pharma will defer a $65.5m capital return to shareholders by at least two… read more
